Biosurgery Market categories the global market by Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive), Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) & Geography. Discover the factors impacting the growth & opportunities.
The report "Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023", The biosurgery market is expected to reach USD 15.58 billion by 2023 from an estimated USD 11.36 billion in 2018, at a CAGR of 6.5 %. Currently, the global biosurgery market is driven by the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients.
However, the high price of biosurgery products and rising cost of surgical procedures may restrict the growth of this market during the forecast period to a certain extent.
Some of the major players operating in this market include Baxter International, Inc.
(US), C.R. Bard, Inc. (US), Johnson & Johnson (US), Medtronic plc (Ireland), Sanofi Group (France), B. Braun Melsungen AG (Germany), MAQUET Holding B.V.
& Co. KG. (Germany), CryoLife, Inc. (US), Stryker Corporation (US), Hemostasis, LLC.
(US), Integra Lifesciences Holdings Corporation (US), Cohera Medical Inc. (US), Pfizer Inc. (US), and CSL Limited (Australia).
- Biosurgery product manufacturers
- Biosurgery product distributors and suppliers
- Healthcare providers
- Medical device manufacturers
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
Browse 352 market data Tables and 56 Figures spread through 314 Pages and in-depth TOC on "Biosurgery Market".
Download PDF Brochure: www.marketsandmarkets.com/pdfdownload.asp?id=166922302
The market is segmented based on products, applications, and regions. Based on the product type, the bone-graft substitutes segment accounted for the largest share of the market in 2017.
The large share of this segment is attributed to the increasing use of bone-graft substitutes across different types of orthopedic surgeries as they reduce surgical time. The focus on new orthobiologic materials like stem cell bone grafts and bone-graft substitutes is also increasing as they have fewer limitations compared to autografts (such as the potential risk of infections and donor site morbidity).
By application, the biosurgery market is segmented into gynecological surgery, general surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, reconstructive surgery, urological surgery, and thoracic surgery. The orthopedic surgery segment accounted for the largest share of the market in 2017.
The large share of this segment is primarily attributed to the large number of orthopedic bone and soft tissue repair surgeries being performed globally, on an annual basis. The growing number of orthopedic surgeries is in turn expected to support the growth of dependent markets, such as the biosurgery market for orthopedic applications.
Geographically, the global biosurgery market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest share of this market in 2017.
This is primarily due to the increasing aging population, increasing number of trauma injuries and the consequent growth in the number of surgical procedures, higher government expenditure on healthcare, well-established healthcare services, and advance technological adaption across North America.
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...